Loading
ביוליין אר אקס is a listed company. Its insiders report their share dealings to TASE (ISA). The last twelve months, up to 18 October 2026, brought 3 filings signed by 3 insiders.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Compared with its exchange (530 companies, median 14 filings), a count of 3 filings is below the norm.
No insider has bought ביוליין אר אקס shares on the open market in the past twelve months.
This summary is built from TASE (ISA) disclosures alone and does not predict where the share price will go.
· cache
3 of 3 declarations
Bioline RX is a publicly traded company on the Tel Aviv Stock Exchange, specializing in the development of biopharmaceutical products. It focuses on innovative solutions for the treatment of serious diseases.